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A novel colicin type, designated colicin FY, was found to be encoded and produced by the strain Yersinia frederiksenii Y27601.
Colicin FY was active against both pathogenic and nonpathogenic strains of the genus Yersinia. Plasmid YF27601 (5,574 bp) of Y.
frederiksenii Y27601 was completely sequenced. The colicin FY activity gene (cfyA) and the colicin FY immunity gene (cfyI) were
identified. The deduced amino acid sequence of colicin FY was very similar in its C-terminal pore-forming domain to colicin Ib
(69% identity in the last 178 amino acid residues), indicating pore forming as its lethal mode of action. Transposonmutagenesis
of the colicin FY-susceptible strain Yersinia kristensenii Y276 revealed the yiuR gene (ykris001_4440), which encodes the YiuR
outer membrane protein with unknown function, as the colicin FY receptor molecule. Introduction of the yiuR gene into the co-
licin FY-resistant strain Y. kristensenii Y104 restored its susceptibility to colicin FY. In contrast, the colicin FY-resistant strain
Escherichia coli TOP10F= acquired susceptibility to colicin FY only when both the yiuR and tonB genes from Y. kristensenii Y276
were introduced. Similarities between colicins FY and Ib, similarities between the Cir and YiuR receptors, and the detected par-
tial cross-immunity of colicin FY and colicin Ib producers suggest a common evolutionary origin of the colicin FY-YiuR and coli-
cin Ib-Cir systems.
Colicins are proteinaceous antimicrobial agents produced byEscherichia coli strains and other related species and genera of
the family Enterobacteriaceae. All of them share a similar molecu-
lar structure comprising three domains for colicin translocation,
receptor binding, and lethal effect (11). To date, more than 20
various colicin types have been described on the molecular level
(11, 52, 57, 64, 68). Although most of the colicin types were iden-
tified amongE. coli strains, bacteriocinswith amolecular structure
similar to that of colicins have been found among strains of the
genera Citrobacter, Escherichia, Klebsiella, Pseudomonas, Salmo-
nella, Shigella, Yersinia, and others (11, 32, 43, 61, 68).
Colicins are directed against closely related strains of the pro-
ducer’s species, and therefore, colicinogenic strains are believed to
have a selective advantage compared to related noncolicinogenic
strains. In general, colicins are directed against both commensal
and pathogenic E. coli strains, except for colicin Js, which is active
against enteroinvasive E. coli, just as Shigella strains (28, 65). Al-
though the precise general role of colicins in the human gut is
unknown, there is increasing evidence for bacteriocin-enhanced
E. coli colonization of the gastrointestinal tract (21), for the role of
colicins in bacterial virulence (e.g., colicin E1 [62]), and for coli-
cin’s role in the probiotic phenotype of E. coli strains (14, 63).
Three of 17 species of the genus Yersinia (Enterobacteriaceae)
are known as important human pathogens (Y. pestis, Y. enteroco-
litica, and Y. pseudotuberculosis), while the other species comprise
nonpathogenic strains or opportunistic pathogens (30, 42, 46, 47,
70, 71, 73). Production of bacteriocins has already been described
in two pathogenic (Y. pestis and Y. pseudotuberculosis) and in two
nonpathogenic (Y. intermedia and Y. kristensenii) Yersinia species
(4, 5, 8, 60, 77).However, only pesticin I has been characterized on
the molecular level as being active against strains of Y. pestis, Y.
pseudotuberculosis, and E. coli C6 () (4, 8, 29, 54, 55, 80).
In this communication, we describe a novel colicin type (FY)
isolated from a strain of Yersinia frederiksenii, its complete plas-
mid sequence (pYF27601), the corresponding receptor, translo-
cation routes to susceptible strains, and activity spectra against
strains of related species.
MATERIALS AND METHODS
Bacterial strains. Colicin FY producer Y. frederiksenii strain Y27601 was
obtained from The National Reference Laboratory for Salmonellae, Na-
tional Institute of Public Health, Prague, Czech Republic. The following
Yersinia strains tested as possible indicators for this colicin were obtained
from the same institution: Y. frederiksenii (strains Y62, Y71, Y81, Y172,
Y284, Y296, Y26851, Y27334, Y27411, Y27477, Y27601, Y27627, and
Y27829), Y. intermedia (strains Y67, Y223, Y308, Y418, Y498, Y546,
Y22377, Y25448, and Y27471), Y. kristensenii (strains Y104, Y276, Y281,
Y330, Y476, Y541, Y599, Y610, Y611, Y612, Y613, Y614, Y615, Y27637,
and Y29196), Y. aldovae (strains Y551, Y552, Y20198, Y21698, Y22412,
and Y25525), Y. rohdei (strains Y80, Y88, Y137, and Y559), Y. ruckerii
(strains Y136, Y22505, Y28544, Y28545, Y28590, and Y28631), Y. pseudo-
tuberculosis (strains 3Ye06, 4Ye06, 1Ye09, 3Ye09, Y140, Y241, Y384,
Y16953, Y19236, Y20462, Y20723, Y22721, Y26579, Y28790, and
Y207240), and Y. enterocolitica (strains 1Ye03, 5Ye03, 15Ye03, 1Ye06,
5Ye06, 7Ye06, 3Ye07, 6Ye07, 7Ye07, 1Ye08, 2Ye08, 3Ye08, 7Ye08, 8Ye08,
4Ye09, 7Ye09, and 1Ye10). Fourteen other tested strains of the species Y.
enterocolitica (strains Y7587, Y7782, Y7886, Y8008, Y8472, Y8703, Y8773,
Y8886, Y9081, Y9102, Y9464, Y9949, Y9953, and Y10141) were isolated
from patients at the Faculty Hospital Brno-Bohunice in Brno, Czech Re-
public. The standard colicin indicator strains used were E. coli K-12 Row,
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C6 (), B1, and P400 and Shigella sonnei strain 17 (62, 67). A list of the
other strains, plasmids, and primers used in this work is shown in Table 1.
Culture media. TY medium consisting of 8 g/liter tryptone (Hi-Me-
dia, Mumbai, India), 5 g/liter yeast extract (Hi-Media), and 5 g/liter so-
dium chloride in water was used throughout the study. TY agar consisted
of a base layer (1.5%, wt/vol) and a top layer (0.75%, wt/vol). For protease
sensitivity testing, 0.005% (wt/vol) trypsin (Sigma, St. Louis, MO) was
added to 1.5% agar. Chloramphenicol (0.025 g/liter; Sigma), kanamycin
(0.050 g/liter; Sigma), or ampicillin (0.100 g/liter; Sigma) was added for
selection or maintenance of plasmids. For induction of colicin synthesis,
mitomycin C (0.0005 g/liter; Sigma) or L-()-arabinose (0.2 g/liter;
Sigma) was added to the culturemedium 4 h prior to bacterial harvesting.
Detection of colicin production.Detection of colicin production was
performed as described previously (69). Briefly, the agar plates were inoc-
ulated by a stab of the producer being tested and incubated at 37°C for 48
h. Themacrocolonies were killed using chloroform vapors (30-min expo-
sure), and each plate was then overlaid with a thin layer of top agar con-
taining 108 cells of an indicator strain. The plates were then incubated at
37°C overnight, and zones of growth inhibition were read.
Preparation of crude colicin extracts and colicin activity assays.
Strains Y. frederiksenii Y27601 and PK11.3 (Table 1) were used for colicin
FY production. A 20-fold-diluted overnight TY culture of a colicinogenic
strain, induced by mitomycin C, was incubated for an additional 4 h and
centrifuged for 15min at 4,000 g; the sediment was resuspended in 5ml
of distilled water, washed twice in distilled water, and sonicated. The re-
sulting bacterial lysate was centrifuged for 15 min at 4,000  g, and the
supernatant was used as a crude colicin preparation. Antibacterial colicin
activity was tested by spotting of 10-fold serial dilutions of crude colicins
on agar plates with inoculated indicator strains. The indicator bacteria
(108 cells) were added to the 3-ml top layer of TY agar and poured on a TY
plate. The reciprocal of the highest dilution of the colicin-containing cell
lysate or purified colicin solution causing growth inhibition of susceptible
bacteria was considered the colicin titer (in arbitrary units). The data
represent the average results of three independent experiments.
Isolation of plasmid YF27601, in vitro transposition, and DNA se-
quencing and annotation. Plasmid DNA was isolated using a QIAprep
spin miniprep kit and Qiagen plasmid midikit (Qiagen, Hilden, Ger-
many). The manufacturer’s recommendations were followed. Plasmid
mutagenesis was performed using an in vitro Tn7 transposition system
(GPS-1 genome priming system, New England BioLabs, Beverly, MA)
according to the manufacturer’s recommendations. The DNA in the vi-
cinity of the inserted Tn7 transposon was sequenced using primers
Tn7RN and Tn7LS. Plasmid DNA of recombinant strains PK11.1 and
PK11.2 was used to construct small insert libraries using the pUC18 vec-
tor. Ninety-six colonies were dideoxy terminator sequenced using pUC18
primers for each pPK11.1 and pPK11.2 template. DNA sequencing was
performed using a Taq DyeDeoxy terminator cycle sequencing kit (Ap-
plied Biosystems, Foster City, CA). Gene predictions and annotations
were performed using Glimmer software (version 3.02; http://www.cbcb
.umd.edu/software/glimmer/) (16) and GeneMark software (http://exon
.biology.gatech.edu/) (41). The Lasergene program package (DNAStar,
Madison, WI) was used for manipulation and assembly of the sequence
data.
Chromosome mutagenesis and identification of receptor mutants.
The chromosomal in vivo mutagenesis protocol (58) was used for trans-
poson inactivation of the colicin FY receptor gene of susceptible Y. kris-
tensenii Y276. Plasmid NKBOR was isolated from the E. coli DH5 pir
strain and subsequently electroporated to Y. kristensenii Y276. Recombi-
nant colonies were placed on 1.5% TY agar containing kanamycin (0.050
g/liter) and colicin FY (200 l of crude sterile lysate, 100 arbitrary units).
The resulting colonies were picked and cultivated in liquid TY medium
overnight, and then their susceptibility to colicin FY was verified using the
colicin activity assays described above. The standard cetyltrimethylam-
monium bromide method was used to isolate the chromosomal DNA
from colicin FY-resistant mutants. Phenol-chloroform extraction was
used to purify the chromosomal DNA (59). Chromosomal DNA (1 to 5
mg) was digested using 5 U of EcoRI (New England BioLabs) (or alterna-
tively the SpeI or EciI enzyme) at 37°C for 3 h, and the restriction digestion
TABLE 1 Strains, plasmids, and primers used in this study
Plasmid, strain, or primer Description or relevant characteristic(s) Source or reference
Plasmids
pYF27601 Colicinogenic plasmid from Y. frederiksenii Y27601 This study
pNKBOR Suicide vector 58
pCR 2.1-TOPO Commercial cloning vector Invitrogen
pBAD-A Commercial expression vector Invitrogen
pDS1006 pCR 2.1-TOPO carrying cfyA to cfyI from Y. frederiksenii Y27601 This study
pDS1068 pBAD-A carrying cfyA to cfyI from Y. frederiksenii Y27601 This study
pDS1088 pCR 2.1-TOPO carrying yiuBCR from Y. kristensenii Y276 This study
pDS1082 pCR 2.1-TOPO carrying yiuR from Y. kristensenii Y276 This study
pDS1091 pCR 2.1-TOPO carrying yiuR and tonB from Y. kristensenii Y276 This study
Strains
E. coli DH5 pir DH5derived strain expressing the R6K  protein 58
E. coli DH10B Commercial cloning strain 25
E. coli TOP10F= Commercial expression strain Invitrogen
PK11.1 to PK11.12 12 strains of E. coli DH10B containing Tn7 insertion in pYF27601 This study
Primers
NKBORout3 5=-AACAAGCCAGGGATGTAACG-3= This study
NKBORout4 5=-GCAGGGCTTTATTGATTCCA-3= This study
colYF-XhoI-F 5=-AGGACTCGAGATGACAGATTATAAAGATGTTGATCCG-3= This study
immYF 5=-AGGACTCGAGATGGATATTAGATACTATATAAAAAATATA-3= This study
YE1459SD-F 5=-ACCGAAATAAATGAGCCTATCCACTGAAT-3= This study
YE1461SD-F 5=-ACCGAAATAAATGGCTAAGGCCTTTAGG-3= This study
YE1461-R 5=-TTAGAAATCGTAGCTGGCGCCCAC-3= This study
infusionYE2222F 5=-CTGGCGGCCGCTCGAGATGCAGCTAAATAAATTTTTCTTGGGTCGACGGC-3= This study
infusionYE2222R 5=-AATTGGGCCCTCTAGATTAGTCCATTTCCGTCGTGCCGCCAATT-3= This study
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was stopped by heat inactivation. T4 ligase (New England BioLabs) was
added to the digested DNA, and the mixture was incubated at 16°C for 16
h. A ligation mixture was used as a template for PCR amplification using
aGeneAmpXL PCR kit (RocheMolecular Systems, Branchburg, NJ) with
primersNKBORout3 andNKBORout4. The resulting PCRproducts were
sequenced with these primers by the Sanger method.
Colicin FY purification and immunoblot analysis. The colicin FY
gene (cfyA, colicin FY activity) was amplified together with the immunity
gene (cfyI, colicin FY immunity) using the colYF-XhoI-F and immYF
primers (Table 1). The PCR product (1.7 kb) was cloned using a TOPO
TA cloning kit (Invitrogen, Carlsbad, CA), resulting in pDS1006. The cfyA
and cfyI genes were then recloned into pBAD-A vector (Invitrogen),
where cfyA was fused at its 5= end to DNA encoding the His tag. The
resulting pDS1068 was transformed into the expression strain E. coli
TOP10F=. Colicin FY was prepurified from overnight culture (5 liters) of
E. coli TOP10F=(pDS1068) using Ni-nitrilotriacetic acid agarose (Qia-
gen). Prepurified colicin FY was further separated from other proteins
using the AKTA fast protein liquid chromatography system (GE Health-
care, Fairfield, CT) andMonoQ 5/50 GL columns (GE Healthcare). Puri-
fied colicin FY samples were mixed with 2 Laemmli sample buffer and
boiled for 10 min. Samples were separated on SDS-PAGE gels (12%) and
electrotransferred (100 V/1 h) onto Immobilon-P transfer membrane
(Millipore, Billerica). The His-tagged colicin FY was detected using a
Penta-His horseradish peroxidase conjugate kit (Qiagen) and a chemilu-
minescent reagent, Lumi-Light Western blotting substrate (Roche, Bran-
ford, CT). The His tag was removed from the colicin FY (500 ng) by
treatment with 5 U of enterokinase (New England BioLabs) at 25°C for
90 min.
Cloning of colicin FY receptor and complementation of resistant
bacteria. The yiuR gene encoding the receptor of colicin FY was amplified
from the chromosomalDNAof susceptible strainY. kristenseniiY276with
YE1461SD-F and YE1461-R primers and Pfu polymerase (Fermentas,
Glen Burnie,MD). The resulting PCR product (1,974 bp) was cloned into
the pCR 2.1-TOPO TA cloning vector, and the resulting plasmid
(pDS1082) was verified by sequencing and transformed into resistant Y.
kristenseniiY104, E. coliTOP10F=, andY. pseudotuberculosisY207240. The
whole yiu locus (yiuBCR genes) was cloned similarly using primers
YE1459SD-F and YE1461-R, resulting in pDS1088. The tonB gene fromY.
kristensenii Y276 was cloned using an In-Fusion advantage PCR cloning
kit (Clontech, Mountain View, CA) using primers infusionYE2222F and
infusionYE2222R. The resulting plasmid (pDS1091) was verified by se-
quencing and transformed into resistant E. coli TOP10F=. The colicin FY
activity assays were used to determine the susceptibility of the trans-
formed bacteria to colicin FY.
Construction of phylogenetic trees. The software PAUP* 4b10 (82)
and its free graphical user interface PaupUp (version 1.0.3.1. beta; http:
//www.agro-montpellier.fr/sppe/Recherche/JFM/PaupUp/) were used
for construction of phylogenetic trees using the nucleotide sequences of
the 3= ends (500 bp) of colicin activity genes. The DNA sequences used
for tree constructions were aligned using ClustalX software, which is
available on-line (version 2.0; http://www.clustal.org/) (40), andModelT-
est (version 3.7; http://darwin.uvigo.es/software/modeltest.html) (53)
was used to identify the best model of nucleotide substitutions. Phyloge-
netic trees were constructed by the maximum-likelihood method from
the bestmodel identified byModelTest. TreeView software (version 1.6.6;
http://taxonomy.zoology.gla.ac.uk/rod/treeview.html) (48) was used for
graphical presentations of the corresponding trees.
Prediction of protein structures. The positions of external loops in
the YiuR protein were predicted by the hidden Markov model method
(http://biophysics.biol.uoa.gr/PRED-TMBB/) (2, 3).
Nucleotide sequence accession numbers.The nucleotide sequence of
plasmid YF27601was deposited in the GenBank database under accession
number JF937655. The yiuR and tonB gene sequences of Y. kristensenii
strain Y276 were deposited under accession numbers JF937653 and
JF937654, respectively.
RESULTS
Inhibitory spectrum of colicin FY. Colicin FY, produced by the
strain Y. frederiksenii Y27601, inhibited the growth of strains be-
longing to five of the eight species of the genus Yersinia tested,
including Y. frederiksenii (3 susceptible strains out of 13 tested), Y.
intermedia (2 out of 9), Y. kristensenii (5 out of 15), Y. aldovae (4
out of 6), and Y. enterocolitica (30 out of 31). Four tested bacterial
strains of Y. rohdei, six strains of Y. ruckeri, and 15 strains of Y.
pseudotuberculosis were found not to be susceptible to colicin FY
(Table 2). None of the standard colicin indicator strains K-12
Row, C6 (), B1, P400, and S. sonnei 17 (62) were susceptible to
this colicin.
Isolation and sequencing of plasmid YF27601. In order to
identify the plasmid encoding colicin FY, the total plasmidDNAof
the strain Y. frederiksenii Y27601 was subjected to in vitro trans-
poson mutagenesis with Tn7. The recombinant DNA was used to
transform E. coli DH10B. Selection for chloramphenicol resis-
tance resulted in 12 recombinant colonies (named PK11.1 to
PK11.12). The PK11.8 strain was excluded because of ambiguous
sequencing results. Nine of the remaining 11 colonies were able to
inhibit Y. kristenseniiY276 indicator bacteria. PlasmidDNAprep-
arations of strains PK11.1 and PK11.2 were used to construct a
small insert library. The resulting clones were used for sequencing
of the plasmid DNA (96 clones of each plasmid). More than 16
average sequencing coverage was obtained for both pPK11.1 and
pPK11.2. In addition, specific oligonucleotides were used to finish
the complete plasmid sequence. The complete plasmid DNA (ex-
cluding the transposon DNA sequence) comprised 5,574 bp, and
the plasmid was named pYF27601 (Fig. 1).
Sequence analysis of pYF27601. The complete sequence of
pYF27601 was numbered from the unique BamHI restriction tar-
get site starting with its first recognized nucleotide (GGATCC).
The pYF27601 sequence comprised 8 predicted open reading
frames (ORFs) encoding polypeptides longer than 50 amino acid
residues (Table 3). The average GC content of this plasmid se-
quence was 50.0%; however, the colicin FY-encoding gene and
colicin FY immunity gene showed lower GC contents (42.1%
and 30.7%, respectively). Three ORF types with predicted func-
tions were found in pYF27601, including ORFs encoding plasmid
mobilization (mobA andmobC) and colicin production (cfyA and
cfyI) and ORFs homologous to ORFs present in insertion se-
quence elements (isnA and isnB). A 964-nucleotide (nt) sequence
of pYF27601 (nt 5497 to 886) was found to be very similar (77%
nucleotide sequence identity) to the origin of replication of plas-
mid AlvA of H. alvei (81). In this 964-nt region of pYF27601, the
RNAI and RNAII promoter sequences (35 and 10 regions)
TABLE 2 Inhibitory spectrum of colicin FY in the genus Yersinia
Yersinia species
No. of colicin FY-susceptible
strains/no. tested (%)
Y. frederiksenii 3/13 (23.08)
Y. intermedia 2/9 (22.22)
Y. kristensenii 5/15 (33.33)
Y. aldovae 4/6 (66.67)
Y. enterocolitica 30/31 (96.77)
Y. pseudotuberculosis 0/15 (0.00)
Y. rohdei 0/4 (0.00)
Y. ruckeri 0/6 (0.00)
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were identified based on similarity to corresponding sequences of
pAlvA and pColE1.
Analysis of the colicin FY activity and immunity genes. The
colicin FY-encoding gene was named cfyA, and the corresponding
protein CfyA contained 438 amino acid residues with a calculated
molecular mass of 49.6 kDa. Colicin FY synthesis in PK11.1 and
PK11.2 was inactivated by Tn7 insertion into the cfyA gene with
insertion target sequences between coordinates 3047 to 3051 and
3613 to 3617, respectively. Upstream from cfyA, a ribosome bind-
ing site (AGGGA, coordinates on pYF27601, 2897 to 2901), puta-
FIG 1 Map of plasmid YF27601 (5,574 bp). The localization and polarity of predicted genes, the positions of several restriction target sites, the RNAI- and
RNAII-encoding inc (incompatibility) region, and the position of the putative origin of replication (ori) are indicated. The colicin FY activity and immunity genes
are shown as gray arrows.
TABLE 3 Identified ORFs and regulatory regions in pYF27601 and their characteristics
ORF












1 () 155–682 —a 175 58.5
2 () 645–1058 — 137 55.0
3 () 1005–1346 Mobilization protein MobC 113 H. alvei (81) 61.1 56 107
4 () 1336–2799 Mobilization nuclease MobA 487 H. alvei (81) 57.9 52 459
5 () 2908–4224 Colicin 438 A. nasoniae (83) 42.1 44 436
6 () 4238–4576 Immunity protein for colicin Ib 112 S. sonnei P9 (NP_052460) 30.7 37 111
7 () 4692–5195 IS1 transposase B 167 E. coli K-12 (56) 54.6 100 167
8 () 5114–5389 IS1 transposase A 91 E. coliH10407 (13) 53 99 91
() 79–108 RNAI promoter (3510 region) H. alvei (81) 93 28
() 5504–5532 RNAII promoter (3510 region) H. alvei (81) 62 18
a —, no similarity found.
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tive promoter10 and35 regions (TTGACA, 2817 to 2822, and
TAGTAT, 2840 to 2845), and a single LexA binding site (CTGTA
TGTATATACAG, 2853 to 2868)were found. The cfyI gene encod-
ing the colicin FY immunity protein was oriented opposite to cfyA
and a near-consensus promoter (10 and 35 sequences) was
found upstream from the cfyI gene (TTGACA, 4660 to 4665, and
TAAAAA, 4636 to 4641). In addition, 13-bp inverted repeats were
found in the 3= region of the cfyI gene and in the intergenic region
of cfyA-cfyI (4229 to 4241 and 4252 to 4264). These repeats repre-
sent potential transcription termination sites.
The deduced amino acid sequence of colicin FY revealed rela-
tively low homology in the 260-amino-acid-long N-terminal and
central sequence, including 31% amino acid identity with an un-
characterized colicin from Arsenophonus nasoniae (CBA74339)
and 28% identity with an S-type pyocin domain-containing pro-
tein of Serratia proteamaculans 568 (YP_001476768), which sug-
gested novel receptor specificity of colicin FY. At theN terminus of
colicin FY, a near-consensus TonB box was found between amino
acid residues 42 and 48 (DTMTVTG), indicating a possible inter-
action between colicin FY and the TonB protein. The last 178
amino acid residues, the C-terminal domain of colicin FY, showed
69% identity with the C-terminal domain of colicin Ib, encoded in
the genome of Yersinia ruckeri ATCC 29473 (ZP_04617830), and
57% identity with the C-terminal domain of colicin Ib of Escherichia
fergusoniiEF6 (AF_453413.1)The pore-forming activity of colicin FY
was verifiedby lipidbilayer experiments (R. Fišer, unpublisheddata).
The immunity protein of colicin FY showed 39% identity in 105
aligned residues to the immunity protein from A. nasoniae
(CBA74337) and 37% identity in 111 aligned residues to the immu-
nity protein of colicin Ib from S. sonnei P9 (NP_052460).
Purification of colicin FY.The E. coliTOP10F= strain, contain-
ing pDS1068 encoding colicin FYwith anN-terminalHis tag (HT-
colicin FY), was used to produce larger amounts of HT-colicin FY
for purification. HT-colicin FY was purified (0.1 mg/ml; i.e., ap-
proximately 1012 molecules per l) with a corresponding activity
of 100 arbitrary units per l. Removal of the His tag from puri-
fied HT-colicin FY resulted in 10-fold increased activity of co-
licin FY compared to that of HT-colicin FY. This fact indicated
the importance of an intact colicin N terminus in its bacteri-
cidal activity (Fig. 2).
Identification and characterization of colicin FY receptor.
Transposon mutagenesis with suicide plasmid NKBOR (58)
and selection for resistance to kanamycin and to colicin FY
resulted in 66 colonies of Y. kristensenii Y276. Fifty colonies
were further analyzed, and 42 of them showed complete resis-
tance to colicin FY (to 100 arbitrary units of colicin FY),
whereas 8 colonies showed decreases in susceptibility to colicin
FY of 1 order of magnitude or less (results of transposon mu-
tagenesis are shown in Fig. 3). Twenty-three (out of 50) colo-
nies were sequenced, and 19 of them revealed an insertion
in the yiuR gene (ykris001_4440; GenBank accession no.
ACCA01000005.1). Four clones contained an insertion in one
of the two genes upstream from yiuR (i.e., the yiuB and yiuC
genes). All four insertions in the yiuB or yiuC gene showed
decreases in susceptibility to colicin FY of 1 order of magnitude
and no complete resistance, as detected in yiuR insertions.
To verify the function of the yiuR gene in colicin FY suscepti-
bility, a colicin FY-resistant strain Y. kristensenii Y104 was trans-
formed with pDS1082 harboring the yiuR gene. Susceptibility to
colicin FY was fully restored in this Y. kristensenii Y104 yiuR

strain (Table 4). Susceptibility was also restored in Y. pseudotuber-
culosis strain 207240. In contrast, introduction of the yiuR gene
into the E. coli TOP10F= strain did not result in acquisition of
susceptibility to colicin FY. However, introduction of the yiuR
gene together with tonB from Y. kristensenii (harbored in
pDS1091) intoE. coli resulted in the recombinant strain becoming
fully susceptible to colicin FY.
FIG 2 Purification of colicin FY and its biological activity. (A) Purification of colicin FY containing an N-terminal histidine tag by using Ni and ion-exchange
columns. Lane 1, low-molecular-weight protein standard (PageRuler Prestained Protein Ladder, Fermentas); lane 2, purified colicin FY with an N-terminal
histidine tag; lane 3, purified colicin FY with an enterokinase-cleaved N-terminal histidine tag. A 12% polyacrylamide gel was stained with Coomassie brilliant
blue. The values on the left are molecular sizes in kilodaltons. (B) Antibacterial activity of purified, His-tagged colicin FY on Y. kristensenii Y276 indicator strain.
(C) Antibacterial activity of enterokinase-treated, purified colicin FY. Note that the biological activity of enterokinase-treated, purified colicin FY (with the
N-terminal His tag removed) was increased approximately by an order of magnitude to 103 arbitrary units per l. Based on the estimated number of colicin FY
molecules (1012 in this purified sample) and the number of lethal colicin units in one arbitrary unit for colicins E1 to E9 (arbitrary unit 2 108 lethal units
[66]), one lethal unit (i.e., the lowest number of colicinmolecules able to kill one susceptible bacterium) of colicin FY corresponds to approximately 5molecules.
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DISCUSSION
Although the majority of colicin types have been identified in E.
coli strains, a number of colicins have been identified for the first
time in different enterobacterial strains, including Citrobacter
freundiiCA31 (colicin A; 45), Serratia marcescens JF246 (colicin L;
18), S. sonneiP9 (colicins E2, Ia, and Ib; 12, 38), S. sonnei 7 (colicin
Js; 1), and S. boydii M592 (colicin U; 27). In addition, several
bacteriocins were named differently although the principal fea-
tures of these proteins are similar to those of colicins, including
bacteriocin 28b of S. marcescens N28b (79), pesticin I of Yersinia
pestis A1122 (4, 29), cloacin DF13 of Enterobacter cloacae DF13
(72), and S-type pyocins of Pseudomonas aeruginosa (reviewed in
reference 43). All of the above-mentioned bacteriocins are protease-
sensitive proteins with a modular structure containing receptor,
translocation, andkillingdomains similar to thoseof colicinproteins.
Because of themodular proteinaceous structure, the novel, protease-
sensitive (data not shown) bacteriocin of Y. frederiksenii was named
colicin FY. The letter F remained unused (the originally identified
colicin F was reclassified as colicin E2 [19] in the list of colicin types,
and the index Y stands for Yersinia. Strains of Y. frederiksenii (both
colicin FY susceptible and producer strains) were found among non-
symptomatic fecal carriers, and these strains are generally considered
nonpathogenic ormoderately pathogenic (10, 73). Like other colicin
producers, strains of Y. frederiksenii belong to bacteria living in ani-
mal and human guts, and the producer strains may have a selective
ecological advantage inmicrobiocenoses typical for this environment
(24, 34).
Colicin FY showed an inhibitory effect against strains of several
Yersinia species (five out of eight tested). Interestingly, the highest
number of susceptible strains was found in strains of Y. enteroco-
litica. These strains cause most of the human diarrheal yersinia
infections (especially in children), representing 1 to 9%of all cases
of diarrhea (44, 84). Colicin FY was also active against other non-
pathogenic strains of “enterocolitica-like group” (73), including
Y. frederiksenii,Y. intermedia,Y. kristensenii, andY. aldovae. This is
the first colicin characterized in detail that is active mainly against
the pathogenic species Y. enterocolitica and related “enteroco-
litica-like” species. On the other hand, not a single strain of Y.
pseudotuberculosis was found to be susceptible to colicin FY, de-
spite the fact that both Y. enterocolitica and Y. pseudotuberculosis
are primarily gut pathogens; however, the yiuR genes of the two
species differ significantly, and our results revealed that transfer of
yiuR fromY. kristensenii to strains ofY. pseudotuberculosis resulted
in acquired susceptibility to colicin FY. Therefore, amino acid res-
idues different in both YiuR proteins specify recognition of colicin
FY by this receptor. Residues interacting with colicin FY are likely
to be found on externally exposed loops 1 to 11 of the YiuR recep-
tor (Table 5). For comparison, most of the sites of interaction
between the receptor domain of colicin Ia and the Cir receptor
(homologous to YiuR) were identified in Cir loops L7 and L8 (9).
Interestingly, these loops in the YiuR receptor are the longest and
most divergent between Y. kristensenii and Y. pseudotuberculosis
(Table 5) and may therefore specify interaction with colicin FY.
As shown bymultilocus sequencing, Y. pestis and Y. pseudotuber-
culosis are very closely related and represent two lineages of the same
species (39). Y. pestis strains are known to possess a yiuR gene (35)
that is very closely related to the yiuR gene of Y. pseudotuberculosis,
and therefore, strains of Y. pestis are unlikely to be susceptible to
colicin FY.
Colicin FYwas found to be encoded by a low-molecular-weight
FIG 3 Schematic representation of the yiuBCR chromosomal genes of Y. kristenseniiY276. Black circles indicate Tn7 insertions that result in complete resistance
to colicin FY, while white circles represent a Tn7 insertions that cause slight decreases in susceptibility (up to 1 order ofmagnitude) to colicin FY.Due to proximity
at transposon insertions, six black circles are not shown. A putative Fur box and a putative promoter region (10 and35 sequences) upstream from yiuB are
indicated. Coordinates taken from the genome sequence of Y. enterocolitica (75) for each yiuBCR gene are indicated. The partial decrease in susceptibility to
colicin FY caused by insertions in yiuB or yiuC likely resulted from a decreased rate of yiuR transcription from the promoter region upstream of the yiuB gene.
TABLE 4 Complementation of colicin FY-resistant strains and their susceptibility to colicin FY
Strain tested Susceptibility to colicin FY
a Relevant genotype
Y. kristensenii Y104 R Control
Y. kristensenii Y104(pDS1082) S (2) yiuR from Y. kristensenii Y276
Y. kristensenii Y104(pDS1088) S (2) yiuBCR from Y. kristensenii Y276
Y. pseudotuberculosis Y207240 R Control
Y. pseudotuberculosis Y207240(pDS1082) S (2) yiuR from Y. kristensenii Y276
E. coli TOP10F= R Control
E. coli TOP10F=(pDS1082) R yiuR from Y. kristensenii Y276
E. coli TOP10F=(pDS1091) S (3) yiuR and tonB from Y. kristensenii Y276
a The values in parentheses indicate the reciprocal highest colicin dilutions active on bacteria (e.g., 2 102). R, resistance; S, susceptibility.
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plasmid named YF27601 (5.6 kb). Colicin plasmids of this type
encode both Tol-dependent colicins (e.g., colicins A, E1-E9, K, N,
S4, U, and Y) and TonB-dependent colicins (e.g., colicins 5 and
10) and have the kil gene as part of the colicin-encoding plasmid
region. As in pesticin I-encoding plasmids (51, 54), the FY-encod-
ing region does not contain the gene for the lytic protein (kil).
Except of colicin FY activity and immunity genes, genes for plas-
mid maintenance (plasmid mobilization) and the IS1 sequence
(encoding transposase) were found on pYF27601. Like other co-
licin plasmids, including ColE1, ColJs, ColK, Col-Let, ColE2, etc.,
the primary role of this plasmid is probably the synthesis of colicin
FY itself. Based on sequence homology, pYF27601 replicates using
the theta mechanism, which is similar to AlvA- and other ColE1-
type plasmids (31, 49, 57, 74, 81). However, due to sequence di-
versity, only the promoter regions of RNAI and RNAII were pre-
dicted (Table 3). Although the precise transcription starts of RNAI
and RNAII genes are not known, the complementary regions of
RNAI and RNAII molecules specified plasmid incompatibility.
The overlapping RNAI and RNAII sequences (incompatibility re-
gion) differ substantially (70% identity) between pYF27601 and
pColE1 (26, 76). This prediction was verified experimentally;
pYF27601 was stably maintained in TOP10F= bacteria with pCR
2.1-TOPO, a vector containing pColE1-derived replication (data
not shown). Therefore, pYF27601 is likely to be compatible with
ColE1-like plasmids.
Sequence analysis of the colicin FY-encoding region revealed a
single LexAbinding site (SOS box), suggesting a lower level of SOS
induction of colicin FY synthesis. In addition to colicin FY, other
colicin gene clusters (e.g., those encoding colicins Ia, Ib, cloacin
DF13, and some klebicins) have been shown to possess a single
LexA binding site. Colicin synthesis under a single LexA repressor
is increased under noninducing conditions with a lower response
on SOS induction (22). In fact, experimental induction of the SOS
response did not lead to a detectable increase in colicin FY synthe-
sis (data not shown). The cfyI gene encoding the colicin FY immu-
nity protein was found to be oriented opposite to the cfyA gene, a
situation common in all colicin types that does not require propor-
tional synthesisof colicins and thecorresponding immunityproteins,
including pore-forming colicins, peptidoglycan-degrading pesticin I
and colicin M (inhibitor of murein synthesis). In contrast to other
colicin immunity genes of pore-forming colicins, the nearly consen-
sus promoter (10 and35 sequences) upstream from cfyI suggests
relatively strong transcription of the cfyI gene.
Colicin FY and its immunity protein showed the highest simi-
larity to colicin and immunity protein from A. nasoniae and to
colicin Ib and colicin Ib immunity protein Ib, respectively. A.
nasoniae is an entomopathogenic bacterium (Enterobacteriaceae)
related to bacteria of the genera Photorhabdus, Proteus, Serratia,
and Yersinia (15). However, the colicin-encoding region in the
genome of A. nasoniae was predicted without further character-
ization (83). The most closely related characterized colicin type
was pore-forming colicin Ib (Fig. 4), although only a cytotoxic
domain had a similar sequence. In fact, cfyI-positive E. coli strains
were partially immune to colicin Ib (data not shown), suggesting
common ancestry for colicin FY- and Ib-encoding regions.
TABLE 5 Differences in amino acid sequences of YiuR external loops
Loop (position)a
Sequence in:
Y. kristensenii Y276c Y. pseudotuberculosis YPIIId
L1 (178–186) QEDSNSGDI ****K****b
L2 (213–229 RSEDKIIDGYNEQRLRN ***********Q**M**
L3 (253–267) QDRNTTAGRSVALNG **K*S*P**TL****
L4 (290–314) GNSTSYVQRDETRNPSREMKSVDNI ******I**********Q*******
L5 (337–359) EELYDEGNQLASAKDLTKLTRGS *****K****P**S**K****W*
L6 (383–391) DQDENYGTH ***Q*****
L7 (417–450) RSPDLRQATDNWGQITGGK–GDPAIIVGNSSLKPE **********D***LS**GKG*L**L*L***N****
L8 (476–518) TDFKDKITEVRRCTDTTGKASGQCMINGNSYKFISDRTNVDKA ***********N*DI**-NTT***VF**IN*******I*****
L9 (544–563) TQSEQKSGQFSGKPLNQMPK ********A*A*Q*******
L10 (587–614) RGKTSEYLNRTSIGTTTPSYTFVDLGAN ***A********M*SR************
L11 (640–648) NDKVLDGRR *********
a YiuR is a predicted outer membrane -barrel with an N-terminal plug and 11 large extracellular loops. External loops were predicted by the hidden Markov model method
(http://biophysics.biol.uoa.gr/PRED-MBB/).
b Asterisks denote identical amino acid residues in both proteins.
c Colicin FY-sensitive strain.
d Colicin FY-resistant strain.
FIG 4 Unrooted tree of colicin pore-forming domains. The tree was con-
structed from sequence data of colicin genes at the 3= end. The bar scale rep-
resents 0.1 nucleotide substitution per site. Bootstrap values based on 1,000
replications are shown next to branches.
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Since none of the standard colicin E. coli indicators were sus-
ceptible to colicin FY, the Yersinia-specific receptor and/or trans-
location system required by colicin FY was expected. Transposon
mutagenesis revealed yiuR as the gene encoding the putative coli-
cin FY receptor. Although YiuABC proteins were shown to be
involved in the iron acquisition system in Y. pestis, YiuR was not
required for iron uptake (35); as a result, the function of the pre-
dicted outer membrane receptor YiuR protein remains unknown.
YiuR displayed 37% identity with the Cir protein of E. coli in-
volved in iron acquisition and in colicin and microcin uptake (9,
11, 33, 37, 50). Interestingly, introduction of the yiuR gene into E.
coli strain TOP10F= did not restore susceptibility to colicin FY.
However, introduction of both the yiuR and tonB genes from Y.
kristensenii restored the susceptibility of E. coli strain TOP10F= to
colicin FY. The fact that the tonB gene of Y. kristensenii Y276 was
not found by screening of colicin FY-unsusceptible insertion mu-
tants probably reflects a decreased viability of Y. kristensenii tonB
mutants similar to that of Salmonella enterica serovar Typhi (23)
and Escherichia coli strain C6 () tonB mutants (17). The tonB
gene of Y. kristensenii (tonBYK) and the tonB gene from E. coli
DH10B are identical at only 46% of their amino acid residues.
Lack of cross-complementation in E. coli was also described for
TonB of Y. enterocolitica (TonBYE) and TonB of S. marcescens
(TonBSM) (20, 36). The TonBYE protein failed to interact with
colicins (completely withD, Ia, and Ib and partially with B andM)
and also with E. coli receptors (36). The fact that the TonB protein
of E. coli was not able to mediate the translocation of colicin FY
through the bacterial envelope of an E. coli yiuR strain could
result from the inefficient energizing of the YiuR protein by TonB
of E. coli (TonBEC) and/or from inefficient interaction between
colicin FY and TonBEC. The lowest sequence identity was found in
the middle part of the TonB proteins of E. coli and Y. kristensenii,
which was previously described as an important region for inter-
action with TonB boxes of colicins or receptors (7, 20). Although
deletion of Q160 from the TonB protein resulted in colicin-spe-
cific decreased susceptibility (78), deletion of seven amino acids
(157S to Y163) fromTonB caused complete resistance to all of the
colicins tested (78). The authors hypothesized that the Q160 re-
gion may be a part of a larger region that is required for contact
with the outer membrane receptor. TonBEC and TonBYK differ at
position 160 (Q and K, respectively) and only 3 out of 7 amino
acids residues were identical in the 157-to-163 region.
TheTonBbox sequence of YiuRwas identical in all four species
Y. enterocolitica, Y. kristensenii, Y. pestis, and Y. pseudotuberculosis
(DTMVVTA). A very similar TonB box was found in the N ter-
minus of colicin FY (DTMTVTG). In contrast, the TonB box se-
quences of the Cir protein and colicin Ia/Ib are ETMVVTA and
EIMAVDI, respectively. Since it is known that TonB box substi-
tutions leading to inactive mutants can be suppressed by muta-
tions in TonB around position 160 (6), it is likely that TonB boxes
evolved together with TonB proteins. In fact, evolution of colicin
TonB boxes together with TonB could result in novel colicin types
with different spectra of susceptible bacterial strains. The observed
similarity between the Cir and YiuR proteins, together with the
partial cross-immunity of colicin FY and colicin Ib producers, sug-
gests a common evolutionary origin of both the colicin FY-YiuR
and colicin Ib-Cir systems.
The above-described colicin FY is a novel colicin type similar to
previously described colicins with susceptible strains in the genus
Yersinia and is especially active against strains of Y. enterocolitica.
The susceptible yersiniae are killed via YiuR-mediated reception,
TonB-mediated translocation through the cell envelope, and the
pore-forming lethal effect on the cell membrane.
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